5
Total investments
3
Early stage
0
Mid stage
0
Late stage
9y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor/global end user market advisor to founders
May 2024
We help families keep their loved ones safe & connected at home with non wearable fall detection & health monitoring devices. Worry less, connect more!!
Investor
Apr 2018
Liber Pharmaceuticals is a proudly independent, Australian owned and operated manufacturer of high quality personal nicotine vaporisers and pharmaceutical grade e-liquids. Liber Pharmaceuticals has no affiliation with any tobacco manufacturing corporation. Indeed, our products are manufactured with a primary focus on smoking cessation and reducing the harms caused by smoking.
Approximately 70% of Australian smokers say they want to quit smoking, but for a number of reasons don’t, or simply can’t. They need viable alternatives they can trust, understand and easily use to successfully transition away from smoking completely.
Liber Pharmaceuticals’ Nicovape Q devices and liquids are manufactured to the highest possible standards. Wherever possible, we use medical or pharmaceutical standards as the benchmarks for our products. By continuing to focus on quality, safety, efficacy and user experience, Liber Pharmaceuticals intends to pave the way towards a product suitable for medical registration.
Liber Pharmaceuticals pioneered the world's first medically prescribed ENDS service. Since inception we have required medical supervision as an integral step in accessing our Nicovape branded products. We believe the support of a medical professional is the key to encouraging long-term smokers to commence, and continue, their journey away from smoking.
We recognise that while these products can help achieve the goal of a smoke-free Australia, they should not be accessible to youth or non-smokers. Providing access to these products via Pharmacies creates an additional touchpoint of support for smokers and prevents access by youth and non-smokers.
The team at Liber Pharmaceuticals is committed to helping improve smoking cessation rates nationwide and will continue to work in collaboration with medical, scientific and public health stakeholders to ensure that we stay at the very forefront of ENDS technology and innovation.
Angel Investor/Board of Advisors
Feb 2017
JAR Aerospace is a newly founded Tech startup primarily focused on the development and manufacturing of purpose built UAS's with the functional capabilities to service large scale industrial processes. JAR Aerospace Pty Ltd aspires to be at the forefront of innovation whilst still providing excellent customer interactions.
Whilst still in the prototyping phase, JAR Aerospace Pty Ltd has one eye to the future focused on the release of tangible products at the beginning of the financial year.
Experience · 6 entries
All (6)
Investments (5)
2024
Angel Investor/global end user market advisor to founders
May 2024
We help families keep their loved ones safe & connected at home with non wearable fall detection & health monitoring devices. Worry less, connect more!!
2020
Investor
Mar 2020
EAN is the leading professional membership organisation for the most senior Executive Assistants, Personal Assistants, EAs, PAs, Executive PAs and similarly titled professionals in Australia and around the world.
We offer members a broad range of online support services and tools in addition to education and training courses, mentoring programs, conferences and of course regular Networking events.
2018
Investor
Apr 2018
Liber Pharmaceuticals is a proudly independent, Australian owned and operated manufacturer of high quality personal nicotine vaporisers and pharmaceutical grade e-liquids. Liber Pharmaceuticals has no affiliation with any tobacco manufacturing corporation. Indeed, our products are manufactured with a primary focus on smoking cessation and reducing the harms caused by smoking.
Approximately 70% of Australian smokers say they want to quit smoking, but for a number of reasons don’t, or simply can’t. They need viable alternatives they can trust, understand and easily use to successfully transition away from smoking completely.
Liber Pharmaceuticals’ Nicovape Q devices and liquids are manufactured to the highest possible standards. Wherever possible, we use medical or pharmaceutical standards as the benchmarks for our products. By continuing to focus on quality, safety, efficacy and user experience, Liber Pharmaceuticals intends to pave the way towards a product suitable for medical registration.
Liber Pharmaceuticals pioneered the world's first medically prescribed ENDS service. Since inception we have required medical supervision as an integral step in accessing our Nicovape branded products. We believe the support of a medical professional is the key to encouraging long-term smokers to commence, and continue, their journey away from smoking.
We recognise that while these products can help achieve the goal of a smoke-free Australia, they should not be accessible to youth or non-smokers. Providing access to these products via Pharmacies creates an additional touchpoint of support for smokers and prevents access by youth and non-smokers.
The team at Liber Pharmaceuticals is committed to helping improve smoking cessation rates nationwide and will continue to work in collaboration with medical, scientific and public health stakeholders to ensure that we stay at the very forefront of ENDS technology and innovation.
2017
E
envietv
Seed Investor
Nov 2017
Angel Investor/Board of Advisors
Feb 2017
JAR Aerospace is a newly founded Tech startup primarily focused on the development and manufacturing of purpose built UAS's with the functional capabilities to service large scale industrial processes. JAR Aerospace Pty Ltd aspires to be at the forefront of innovation whilst still providing excellent customer interactions.
Whilst still in the prototyping phase, JAR Aerospace Pty Ltd has one eye to the future focused on the release of tangible products at the beginning of the financial year.
Show all 6 entries ↓
Investment activity
2017–2024 · 5 investments
Recent (last 2 years)Earlier
Similar investors
Health Care investors in Australia
Investor lists
Lists that match Tim's portfolio
- Health Care investors in Australia179 investors
- Startup investors in Australia738 investors






